Andrew Bellinger - Jul 20, 2022 Form 4 Insider Report for Verve Therapeutics, Inc. (VERV)

Role
CSO & CMO
Signature
/s/ Andrew Ashe, as Attorney-in-Fact for Andrew Bellinger
Stock symbol
VERV
Transactions as of
Jul 20, 2022
Transactions value $
-$670,200
Form type
4
Date filed
7/22/2022, 05:00 PM
Previous filing
Jul 15, 2022
Next filing
Sep 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERV Common Stock Options Exercise $27.8K +20K +301.7% $1.39* 26.6K Jul 20, 2022 Direct
transaction VERV Common Stock Sale -$698K -20K -75.11% $34.90 6.63K Jul 20, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VERV Stock Option (right to buy) Options Exercise $0 -20K -92.6% $0.00 1.6K Jul 20, 2022 Common Stock 20K $1.39 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 20, 2022.
F2 The option was granted on June 25, 2019 for 21,599 shares. The shares underlying the option vested on May 1, 2020.